AAC TECH (02018) spent 12.3768 million Hong Kong dollars on repurchasing 344,500 shares on January 16th.
Rayson Technology (02018) announced that the company invested 12.3768 million Hong Kong dollars on January 16, 2025...
AAC TECH (02018) announced that the company repurchased 344,500 shares on January 16, 2025 at a total cost of 12.3768 million Hong Kong dollars, with a repurchase price per share ranging from 35.55 to 36.95 Hong Kong dollars.
Related Articles
Jiangsu Kanion Pharmaceutical (600557.SH): The domestic first generic drug simvastatin and ezetimibe sodium tablets have been included in the national medical insurance list.
Shareholder Jiangsu Baixing of Lifecome Biochemistry (002868.SZ) plans to reduce its shareholding by no more than 3%.
China Longyuan Power Group Corporation (00916) completed a total of approximately 69.0964 billion kilowatt hours of electricity in the first 11 months, representing a year-on-year increase of 0.41%.
Jiangsu Kanion Pharmaceutical (600557.SH): The domestic first generic drug simvastatin and ezetimibe sodium tablets have been included in the national medical insurance list.
Shareholder Jiangsu Baixing of Lifecome Biochemistry (002868.SZ) plans to reduce its shareholding by no more than 3%.
China Longyuan Power Group Corporation (00916) completed a total of approximately 69.0964 billion kilowatt hours of electricity in the first 11 months, representing a year-on-year increase of 0.41%.
